Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Avid Bioservices Inc (CDMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 393,120
  • Shares Outstanding, K 56,000
  • Annual Sales, $ 53,620 K
  • Annual Income, $ -21,810 K
  • 36-Month Beta 2.33
  • Price/Sales 7.19
  • Price/Cash Flow N/A
  • Price/Book 6.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 10/31/18
See More
  • Average Estimate -0.09
  • Number of Estimates 3
  • High Estimate -0.02
  • Low Estimate -0.16
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.03 +13.69%
on 08/27/18
8.44 -18.84%
on 09/11/18
+0.61 (+9.78%)
since 08/24/18
3-Month
3.65 +87.67%
on 06/26/18
8.44 -18.84%
on 09/11/18
+3.09 (+82.18%)
since 06/25/18
52-Week
2.24 +205.80%
on 02/15/18
8.44 -18.84%
on 09/11/18
+3.66 (+114.73%)
since 09/25/17

Most Recent Stories

More News
Avid Bioservices to Exhibit at the 17th Annual Contracting & Outsourcing Conference

Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development...

CDMO : 6.85 (-2.42%)
CDMOP : 25.90 (+0.75%)
Avid Bioservices (CDMO) Reports Q1 Loss, Tops Revenue Estimates

Avid Bioservices (CDMO) delivered earnings and revenue surprises of 33.33% and 26.52%, respectively, for the quarter ended July 2018. Do the numbers hold clues to what lies ahead for the stock?

CDMO : 6.85 (-2.42%)
Avid Bioservices Reports Financial Results for First Quarter Fiscal 2019 and Recent Developments

-- Fiscal 2019 Projected Revenue of $51 to $55 Million Reaffirmed --

CDMO : 6.85 (-2.42%)
CDMOP : 25.90 (+0.75%)
Don't Gamble on Biotech! Industry Comps & Smart Investors Indicate Why You Could Generate Big Returns on This Unknown Stock

A newer class of drugs called Cell Therapies offer major advances for some diseases, and this therapy type is expected to boom in the next ten years to a multi-billion dollar market. Top drug companies...

GILD : 74.99 (-0.83%)
CDMO : 6.85 (-2.42%)
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing...

CDMO : 6.85 (-2.42%)
CDMOP : 25.90 (+0.75%)
Avid Bioservices (CDMO) Q1 Earnings Preview: Here's What to Look Out For

Avid Bioservices (CDMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CDMO : 6.85 (-2.42%)
Clinical Trial Developments Increasing Level of Successful Cancer Treatments

MarketNewsUpdates.com News Commentary

ABT : 72.20 (+1.06%)
OPK : 3.99 (-3.39%)
ACAD : 21.41 (+7.86%)
CDMO : 6.85 (-2.42%)
CDMOP : 25.90 (+0.75%)
MBRX : 1.61 (-1.83%)
Avid Bioservices, Mellanox, Berkshire Hathaway, Intel and Chevron highlighted as Zacks Bull and Bear of the Day

Avid Bioservices, Mellanox, Berkshire Hathaway, Intel and Chevron highlighted as Zacks Bull and Bear of the Day

CVX : 123.37 (+0.61%)
INTC : 45.91 (-2.13%)
BRK.B : 218.05 (-0.04%)
CDMO : 6.85 (-2.42%)
MLNX : 76.60 (-0.39%)
Avid Bioservices (CDMO) Reports Q4 Loss, Tops Revenue Estimates

Avid Bioservices (CDMO) delivered earnings and revenue surprises of 6.67% and 6.65%, respectively, for the quarter ended April 2018. Do the numbers hold clues to what lies ahead for the stock?

CDMO : 6.85 (-2.42%)
Options Traders Expect Huge Moves in Avid Bioservices (CDMO) Stock

Avid Bioservices (CDMO) needs investors to pay close attention to the stock based on moves in the options market lately.

CDMO : 6.85 (-2.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade CDMO with:

Business Summary

Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing...

See More

Key Turning Points

2nd Resistance Point 7.20
1st Resistance Point 7.03
Last Price 6.85
1st Support Level 6.76
2nd Support Level 6.66

See More

52-Week High 8.44
Last Price 6.85
Fibonacci 61.8% 6.07
Fibonacci 50% 5.34
Fibonacci 38.2% 4.61
52-Week Low 2.24

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar